Health Technology Assessment World Europe 2011 is the most influential meeting on HTA for pharmaceutical products in your 2011 events calendar.

Come to Health Technology Assessment World Europe 2011 and learn:

• HTA policy and practice in Europe, USA and rest of the World
• HTA in reimbursement decisions
• Cooperation between regulatory bodies and HTA agencies
• How to demonstrate comparative effectiveness and outcomes research
• Case studies of HTA policy, practice and assessment methods
• HTA for speciality and high priced drugs
• Value based pricing, risk sharing schemes and reimbursement
• Role of patients in HTA

Register for Health Technology Assessment World Europe 2011 »
Download the brochure now »
 

An unrivalled speaker line up including:

• MHRA
• BlueCross BlueShield Association
• NICE UK
• G-BA Germany
• EFPIA
• EUnetHTA
• Institute for Health Economics and
  Technology Assessment (IHETA),
  Czech Republic
• Ministry of Public Health, Thailand
• GSK Bio
• HTAi Interest Group for Patient/
  Citizen Involvement in HTA
• and many more!

Register for Health Technology Assessment World Europe 2011 »
Email us now for more details »
 

The Health Technology Assessment World Europe 2011 focus:

• Global update and implications
• Country specific updates/reviews
• Updates from EUnetHTA and European Commission on EU HTA cooperation  and harmonization
• Merging two different worlds: regulatory review and market authorisation
• Patient involvement
• Best practice case studies
   

If you need to know the latest developments in these areas you must attend.
Register now »

If you wish to access senior health economic and outcomes research professionals working in the pharmaceutical and biotech industry you need to be here. There are limited sponsorship opportunities.
Download the brochure now »

Who should attend:

This event will be attended by health agencies, pharmaceutical and
biotech professionals working in the following departments:

• HTA 
• Market Access 
• Health Economics 
• Outcomes Research
• Health Policy 
• Epidemiology 
• Reimbursement  
• Pricing
• Pharmacoeconomics 

Register for Health Technology Assessment World Europe 2011 » 
 

Who should sponsor:

World-class solutions providers who need to position their products and services in front of decision makers from major pharmaceutical and biotechnology companies:

• Contract Research Organisation 
• Consultants
• Niche Contract Research Organisations
• Communications
• IT / software/data providers
   

Download Sponsorship Prospectus »